Novartis signs $400M takeover deal with biotech firm

Novartis AG announced Wednesday that it will acquire Protez Pharmaceuticals, a biotech firm based in Malvern, Pa., for $400 million. The deal grants Novartis rights to PZ-601, an injectable antibiotic developed by Protez to fight potentially lethal drug-resistant infections, including those caused by MRSA and other superbugs.

View Full Article in:

American City Business Journals · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX